Search Results - "Musu, L."

Walking improvements with nabiximols in patients with multiple sclerosis by Coghe, G., Pau, M., Corona, F., Frau, J., Lorefice, L., Fenu, G., Spinicci, G., Mamusa, E., Musu, L., Massole, S., Massa, R., Marrosu, M. G., Cocco, E.

“…Recently, nabiximols was approved as a treatment in MS spasticity. Data leading to approval and clinical use of nabiximols, although widely recognised, are…”
Get full text

An ecologic study of geographical variation in multiple sclerosis risk in central Sardinia, Italy by Montomoli, C, Allemani, C, Solinas, G, Motta, G, Bernardinelli, L, Clemente, S, Murgia, B S, Ticca, A F, Musu, L, Piras, M L, Ferrai, R, Caria, A, Sanna, S, Porcu, O

“…We carried out an ecological study in the most archaic area of Sardinia to obtain a reliable estimate of the prevalence of multiple sclerosis (MS) and to…”
Get more information

Association between the ancestral haplotype HLA A30B18DR3 and multiple sclerosis in central Sardinia by Bitti, P.P., Murgia, B.S., Ticca, A., Ferrai, R., Musu, L., Piras, M.L., Puledda, E., Campo, S., Durando, S., Montomoli, C., Clayton, D.G., Mander, A.P., Bernardinelli, L.

“…Association and linkage studies have established the importance of the major histocompatibility complex (MHC) in the susceptibility for multiple sclerosis…”
Get full text

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis by AMATO, M. P, PORTACCIO, E, SOLARO, C, TOLA, M. R, POZZILLI, C, DE GIGLIO, L, TOTARO, R, LUGARESI, A, DI TOMMASO, V, PAOLICELLI, D, MARROSU, M. G, COMI, G, GHEZZI, A, PELLEGRINI, F, TROJANO, M, HAKIKI, B, ZIPOLI, V, MARTINELLI, V, MOIOLA, L, PATTI, F, LA MANTIA, L, MANCARDI, G. L

“…To assess pregnancy and fetal outcomes after in utero exposure to interferon-β (IFNβ) in all pregnancies occurring in women with multiple sclerosis (MS) during…”
Get full text

Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study by Cocco, E, Sardu, C, Gallo, P, Capra, R, Amato, MP, Trojano, M, Uccelli, A, Marrosu, MG

“…Background Improved prognosis in women with multiple sclerosis (MS) undergoing immunosuppressive treatment with mitoxantrone (MITO) has led to an increased…”
Get full text

Interferon beta therapy and pregnancy outcomes in patients with multiple sclerosis by Portaccio, E, Ghezzi, A, Rizzo, A, Zipoli, V, Hakiki, B, Pellegrini, F, De Giglio, L, Pozzilli, C, Fuiani, A, Trojano, M, Musu, L, Marrosu, MGG, Cavallaro, T, Patti, F

“…Background: Little is known on pregnancy outcome after in utero exposure to beta-interferon (IFNB) therapy. Objective: To assess the impact of IFNB therapy on…”
Get full text

Risk for relatives of patients with multiple sclerosis in central Sardinia, Italy by Prokopenko, Inga, Montomoli, Cristina, Ferrai, Raffaela, Musu, Luigina, Piras, Maria Luisa, Ticca, Anna, Murgia, Bruno S, Bernardinelli, Luisa

“…Multiple sclerosis (MS) is a chronic, inflammatory, disabling disease of the central nervous system, known for its complex interplay between genetic and…”
Get more information

Multiple sclerosis recurrence risk for siblings in an isolated population of Central Sardinia, Italy by Montomoli, Cristina, Prokopenko, Inga, Caria, Antonella, Ferrai, Raffaela, Mander, Adrian, Seaman, Shaun, Musu, Luigina, Piras, Maria L., Ticca, Anna F., Murgia, Salvatore B., Bernardinelli, Luisa

“…Studies of twins, adoptees, half siblings, and familial recurrence risk have shown that genetic and non‐genetic factors are involved in multiple sclerosis (MS)…”
Get full text